NOVIMMUNE
Live / Registered — Registered and renewed (as of 16 Jul 2025)
What this means for you
Registered since 17 Aug 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Aug 2024).
Record
- Serial number
- 75907462
- Registration number
- 2873048
- Mark type
- Word mark
- Filed
- 01 Feb 2000
- Published for opposition
- 24 Feb 2004
- Registered
- 17 Aug 2004
- Next maintenance due
- 17 Aug 2024
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 001 — Chemicals: Chemicals for use in the manufacture of pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, including [ superantigens, ] small molecular weight compounds, polypeptides and monoclonal antibodies
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, namely, superantigens, small molecular weight compounds, polypeptides and monoclonal antibodies; pharmaceutical and veterinary preparations for the treatment of autoimmune diseases, inflammation and for use during transplantation, including diabetes, multiple sclerosis, rheumatoid arthritis and lupus, and for immuno-modulation, namely, immuno-suppression; pharmaceutical and veterinary preparations for the modulation and control of T lymphocyte activation; [ superantigens; superantigens encoded by human endogenous retroviruses; superantigens responsible for T cell activation in autoimmune diseases; regulatory factors responsible for the control of expression of MHC class II molecules, ] regulatory factors that are directly involved in the control of T lymphocyte activation; polypeptides to treat diseases; vaccines; monoclonal antibodies to treat diseases
- Class 042 — Scientific and technological services: legal services; scientific research; chemical research; consulting in the pharmaceutical and biomedical fields
Owner
- NovImmune SA, Geneva, CH
- NovImmune SA, 1207 Geneva, CH
- NovImmune SA, 1207 Geneva, CH
Prosecution history
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Jul 2025 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 16 Jul 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Jul 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 May 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 26 May 2025 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 26 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Feb 2025 — TEAS SECTION 8 & 9 RECEIVED
- 17 Aug 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 20 Apr 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Apr 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Apr 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 20 Apr 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS